Masato Yoshizawa to Treatment Outcome
This is a "connection" page, showing publications Masato Yoshizawa has written about Treatment Outcome.
Connection Strength
0.336
-
Yoshizawa M, Miyawaki Y, Sato H, Kawasaki T, Furube T, Matsui K, Suzuki Y, Toriumi T, Kishimoto Y, Ebara G, Hirano Y, Okamoto K, Sakuramoto S. Esophageal Lymphoepithelioma-like Carcinoma With a Remarkable Response to DCF Chemotherapy: A Case Report. Anticancer Res. 2025 Oct; 45(10):4643-4652.
Score: 0.170
-
Matsui K, Miyawaki Y, Suzuki Y, Furube T, Yoshizawa M, Toriumi T, Ebara G, Sato H, Sakuramoto S. Relationship between immune-related adverse events and long-term survival in patients treated with immune checkpoint inhibitors for unresectable advanced or recurrent esophageal cancer. Dis Esophagus. 2026 Mar 02; 39(2).
Score: 0.044
-
Ishiyama Y, Hirano Y, Sasaki M, Akuta S, Yoshizawa M, Yamato M, Nakanishi A, Minagawa Y, Hayashi H, Fujii T, Okazaki N, Ishii T, Hiranuma C. End-to-end Anastomosis With ECHELON ENDOPATH? Staple Line Reinforcement for Right-sided Colon Cancer: Safety and Feasibility. In Vivo. 2025 May-Jun; 39(3):1573-1579.
Score: 0.041
-
Matsui K, Sakuramoto S, Furube T, Yoshizawa M, Toriumi T, Ebara G, Miyawaki Y, Sato H. Clinical benefits including the postoperative inflammatory status of robot-assisted distal gastrectomy for gastric cancer compared with laparoscopic distal gastrectomy in patients with obesity. J Robot Surg. 2025 Apr 10; 19(1):143.
Score: 0.041
-
Fujii T, Hirano Y, Ishiyama Y, Yamato M, Akuta S, Yoshizawa M, Okazaki N, Hiranuma C. Comparison of short- and mid-term outcomes between the Senhance digital laparoscopic system and laparoscopic colectomy: a propensity score matching study. Surg Endosc. 2025 02; 39(2):1153-1159.
Score: 0.040